Respiratory Syncytial Virus (RSV) Clinical Research Trials

Janssen Vaccines & Prevention B.V. (6)

National Institute of Allergy and Infectious Diseases (NIAID) (4)

Imperial College London (3)

ModernaTX, Inc. (3)

Pfizer (3)

Enanta Pharmaceuticals (2)

Janssen Research & Development, LLC (2)

LumiraDx UK Limited (2)

Meissa Vaccines, Inc. (2)

Merck Sharp & Dohme LLC (2)

ReViral Ltd (2)

Sanofi Pasteur, a Sanofi Company (2)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)

Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. (1)

AlloVir (1)

Association Clinique Thérapeutique Infantile du val de Marne (1)

Bahçeşehir University (1)

Bill & Melinda Gates Medical Research Institute (1)

Hamad Medical Corporation (1)

Hannover Medical School (1)

Institut National de la Santé Et de la Recherche Médicale, France (1)

Janssen Pharmaceutical K.K. (1)

St George's, University of London (1)

St. Olavs Hospital (1)

Universiti Sains Malaysia (1)

University Hospital, Akershus (1)

University Hospitals, Leicester (1)

University of Arizona (1)

University of California, Davis (1)

Uppsala University (1)

No clinical trials found for 'Respiratory Syncytial Virus (RSV)'.